Protocol for the safety of brodalumab regarding psychiatric comorbidities in patients with psoriasis
Introduction Brodalumab, an anti-IL17RA monoclonal antibody, is a treatment option for plaque psoriasis related to increased risk of suicidal ideation and behavior, including completed suicide.However, in the literature no causal relationship is reported, and the reported incidence of patients rece...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cambridge University Press
2022-06-01
|
| Edice: | European Psychiatry |
| Témata: | |
| On-line přístup: | https://www.cambridge.org/core/product/identifier/S0924933822019575/type/journal_article |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
